DCF — WELLINGTON REGL MEDICAL CENTER
Enterprise Value: $-61.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-61.2M
Enterprise Value
$-26.0M
PV of Cash Flows
$-35.1M
PV of Terminal Value
$-56.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $251.5M | $0.3M | 0.0% | $-10.4M | $-9.4M |
| Year 2 | $259.0M | $2.9M | 1.0% | $-8.1M | $-6.7M |
| Year 3 | $266.8M | $5.6M | 2.0% | $-5.7M | $-4.3M |
| Year 4 | $274.8M | $7.2M | 3.0% | $-4.5M | $-3.1M |
| Year 5 | $283.0M | $8.1M | 3.0% | $-4.1M | $-2.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-61.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$244.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.00390742782769808
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5